Extended Data Fig. 2: TRACERx 100 sample selection and patient characteristics.
From: Neoantigen-directed immune escape in lung cancer evolution
a, CONSORT diagram showing the selection of TRACERx 100 patients for RNA-seq and/or pathology TIL estimate analysis. b, Patient characteristics for the TRACERx 100 cohort are shown. Patient characteristics can also be found in Supplementary Table 1.
